Mangalam Drugs promoters declare no encumbrance in FY 2025-26
Promoters of Mangalam Drugs and Organics declared no new encumbrances on shares in FY 2025-26, complying with SEBI regulations. The filing confirms no direct or indirect charges beyond prior disclosures.

*this image is generated using AI for illustrative purposes only.
Promoters of Mangalam Drugs and Organics Limited have confirmed that they did not create any encumbrance on their shares during the financial year 2025-26. This declaration, made on behalf of the promoters and members of the promoter group, ensures that no direct or indirect charges were placed on their holdings other than those already disclosed to the exchanges.
The disclosure was submitted by Shri. Govardhan M. Dhoot, a promoter of the company, to the BSE Ltd and the National Stock Exchange of India. The filing was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates such annual declarations to maintain transparency regarding shareholding patterns.
Key Details of the Filing
| Aspect | Details |
|---|---|
| Regulation | Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
| Financial Year | 2025-26 |
| Declarant | Shri. Govardhan M. Dhoot, Promoter |
| Encumbrance Status | No new encumbrances created |
The declaration covers the promoters, members of the promoter group, and persons acting in concert with them. By confirming the absence of new encumbrances, the company provides assurance to shareholders regarding the stability of the promoter's shareholding structure for the specified period.
Historical Stock Returns for Mangalam Drugs & Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.30% | +0.14% | +0.71% | +22.96% | -62.85% | -79.29% |
How will the absence of new encumbrances impact investor confidence in Mangalam Drugs and Organics Limited?
What are the expected capital allocation strategies of the promoters given their unencumbered shareholding status?
Could this clean shareholding structure position the company for potential mergers, acquisitions, or strategic partnerships?

































